Mira PharmaceuticalsMIRA
13F holders, Q2 2026 (June 30)26holders
4new positions
4sold out
1famous investor
$0.95avg. 13F price*
At the end of Q2 2026, 26 institutions reported holding Mira Pharmaceuticals Inc. (MIRA) in their 13F filings, unchanged from Q1 2026. 4 opened new positions and 4 sold out. The largest holders were Vanguard Capital Management LLC ($712K), Cross Staff Investments Inc ($340K) and Geode Capital Management, LLC ($288K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Mira Pharmaceuticals Inc.
- CUSIP
- 60458C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $116K |
| Exits | 4 | $147K |
All 13F filers, Q1 2026 → Q2 2026: 345,416 shares bought and 177,915 shares sold, net +167,501 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Vanguard Capital Management LLC | 0.00% | Add +8.3% | 751,801 | $712K |
| Cross Staff Investments Inc | 0.19% | No change | 359,401 | $340K |
| Geode Capital Management, LLC | 0.00% | Add +4.5% | 303,882 | $288K |
| BlackRock, Inc. | 0.00% | Add +117.7% | 244,622 | $232K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +0.7% | 170,668 | $162K |
| Captrust Financial Advisors | 0.00% | New | 90,645 | $86K |
| Northern Trust Corp. | 0.00% | Add +0.1% | 67,735 | $64K |
| First American Bank | 0.00% | No change | 60,000 | $57K |
| Commonwealth Equity Services, LLC | 0.00% | Add +51.7% | 53,189 | $50K |
| State Street Corp. | 0.00% | No change | 49,100 | $46K |
| International Assets Investment Management, LLC | 0.00% | No change | 35,000 | $33K |
| Fifth Third Bancorp | 0.00% | No change | 20,000 | $19K |
| Citadel Advisors | 0.00% | New | 18,661 | $18K |
| Susquehanna International Group, LLP | 0.00% | Reduce -26.2% | 18,566 | $18K |
| Mariner, LLC | 0.00% | No change | 16,500 | $16K |
| XTX Topco Ltd | 0.00% | Reduce -56.4% | 16,374 | $15K |
| HRT Financial LP | 0.00% | New | 13,450 | $12K |
| Cary Street Partners Financial LLC | 0.00% | No change | 10,000 | $9K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 8,000 | $8K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $2K |
| UBS Group AG | 0.00% | Reduce -72.5% | 1,772 | $2K |
| Citigroup Inc. | 0.00% | Reduce -71.4% | 1,207 | $1K |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -50.0% | 1,000 | $947 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -89.6% | 517 | $489 |
| Barclays PLC | 0.00% | New | 159 | $150 |
| Caitong International Asset Management Co., Ltd | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is MIRA's weight in each manager's 13F, not the share of Mira Pharmaceuticals Inc. the manager owns.